__NUXT_JSONP__("/drugs/Lisavanbulin", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1263384-43-5",chebiId:b,chemicalFormula:b,definition:"An orally available, highly water-soluble lysine prodrug of the synthetic small molecule BAL27862 with potential antitumor activity. Upon administration of lisavanbulin and conversion into the active form BAL27862, this agent binds to tubulin at a site distinct from the vinca-alkaloid-binding site, and prevents tubulin polymerization and destabilizes microtubules, ultimately leading to cell cycle arrest, blockage of cell division and an induction of cell death in cancer cells.",fdaUniiCode:"5PT0QP06X5",identifier:"C97664",preferredName:a,semanticType:"Organic Chemical",subclassOf:["C25974"],synonyms:["(2S)-2,6-Diamino-N-(4-(2-(2-(4-((2-cyanoethyl)amino)-1,2,5-oxadiazol-3-yl)-1H-benzimidazol-1-yl)acetyl)phenyl)hexanamide","BAL-101553","BAL101553","LISAVANBULIN",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FLisavanbulin",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Lisavanbulin","","2021-10-30T13:48:36.863Z")));